- AVF Academy
- EAVLA Advanced Phlebology Webinar: December 2025
EAVLA Advanced Phlebology Webinar: December 2025
From medical therapy to ablation, foam, and stenting, small decisions shape how patients with chronic venous disease do over time. In this Advanced Phlebology webinar, hosted by the Egyptian African Venous Lymphatic Association (EAVLA) with the American Venous Forum and the Journal of Vascular Surgery: Venous and Lymphatic Disorders, international experts review recent research and share how it changes their practice.
What you’ll learn
- When venoactive drugs such as micronized purified flavonoid fraction (MPFF) make sense: for symptomatic patients awaiting intervention, residual symptoms after successful treatment, patients who are not procedure candidates, as an adjunct to compression for venous leg ulcers, and for persistent symptoms after deep vein thrombosis, since the inflammatory cascade triggered by venous hypertension drives pain, edema, and progression
- Why ablation length matters more than modality: in venous leg ulcers, single-modality nonthermal ablation and thermal ablation with adjunct nonthermal treatment below the knee produced equivalent wound healing, pointing to treating the full length of the refluxing vein
- How ultrasound-guided foam sclerotherapy fits into healing venous leg ulcers, based on a 2025 multicenter study from Egypt and London
- How procedure timing affects iliac vein stenting: in 64 patients with nonthrombotic iliac vein lesions, those treated later in the day had fasted nearly five hours longer, and about nine hours of fasting was associated with roughly a 2 mm smaller stent, suggesting dehydration may lead to undersizing
Agenda
- Venoactive drugs: when to use and when not to, Dr. Ahmed Gaweesh
- Recent JVS-VL research on venous leg ulcers: ablation length and foam sclerotherapy, Dr. Juan Carlos Jimenez
- Timing of outpatient stenting and stent size in nonthrombotic iliac vein lesions, Dr. Cassius Iyad Ochoa Chaar
- Expert discussion and Q&A
Faculty
- Rashad Bishara (Host), President, EAVLA
- Ahmed Gaweesh, MD, Consultant Vascular Surgeon, Vice President, EAVLA
- Juan Carlos Jimenez, UCLA Health, David Geffen School of Medicine
- Cassius Iyad Ochoa Chaar, Yale School of Medicine
- Windsor Ting, MD, Icahn School of Medicine at Mount Sinai
- Ahmet Kürşat Bozkurt, MD, Cerrahpaşa Faculty of Medicine, President, Turkish Society of Cardiovascular Surgery
- Sheila Coogan
- Ruth Bush
- Tomasz Urbanek
- Paola Ortiz
- Tobias Hirsch
- Joana Storino
Recorded live December 6, 2025. Supported by Servier.
Related
Junctional Reflux, Ablation Outcomes, and Early TOTEM Trial Results: Advanc... Junctional Reflux, Ablation Outcomes, and Early TOTEM Trial Results: Advanced Phlebology Webinar
Nov 16, 2026
Learn how junctional reflux affects the success of endovenous ablation for great saphenous vein insufficiency and the first r... more details May 24, 2025
Learn five-year outcomes of ultrasound-guided foam sclerotherapy for saphenous trunk incompetence, how to treat the sub-ulcer... more details Oct 28, 2026
Learn how to diagnose, treat, and manage venous leg ulcers, from duplex ultrasound and intravascular ultrasound workup to abl... more details Oct 21, 2026
Learn when to operate on varicose veins after superficial vein thrombosis, based on real-world INSIGHTS-SVT data, and how pol... more details 


